1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > Influenza Therapeutics--Developments and Trends (Technical Insights)

This research service outlines the technologies on influenza therapeutics.

Table Of Contents

Influenza Therapeutics--Developments and Trends (Technical Insights)
Table of Contents

1 | EXECUTIVE SUMMARY

Industry Overview and Key Research Highlights
1. Industry Overview
2. Key Research Highlights

Scope and Methodology
1. Scope
2. Methodology

2 | GLOBAL RandD NETWORK ANALYSIS

Value Chain Analysis
1. Existing RandD Networks
2. Stakeholders RandD Focus

Environmental Assessment
1. Key Technology Drivers
2. Key Technology Challenges
3. Analysis of the Business Environment--Porter's Analysis
4. Analysis of the Internal Environment--SWOT Analysis

3 | STRATEGIC MANAGEMENT OF RandD

Industry Trends and Requirements
1. Current Industry and Research Trends
2. Technical Resource Competency
3. RandD Intensity
4. Availability of Funding and Future Milestones

RandD Management Strategy
1. Technology Strategy
2. RandD Strategy

New Product Development and Commercialization Strategy
1. Innovation Strategy
2. Intellectual Property (IP) Protection Strategy
3. Conclusion

4 | PATENTS AND KEY CONTACTS

Patents
1. Issued Patents across Industry and Academia
2. Applied Patents across Industries and Academia

Key Participants
1. Participants across Industry
2. Participants across Academia

5 | DECISION SUPPORT DATABASE

DSD Tables
1. Incidence of Haemophilus Influenzae--USA (2004 to 2014)
2. Government Investment in Biotech RandD (Million USD)--World (2004 to 2014)
3. Pharma RandD Expenditure (Million USD)--World (2004 to 2014)
4. Pharmaceutical Market (Billion USD)--World (2004 to 2014)

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Purchase Reports From Reputable Market Research Publishers

Non-Small Cell Lung Cancer: KOL Insight

Non-Small Cell Lung Cancer: KOL Insight

  • $ 7 495
  • Industry report
  • July 2015
  • by Firstword Pharma

Non-Small Cell Lung Cancer: KOL Insight offers detailed expert opinion on the continuing evolution of the treatment paradigm for EGFR/ALK positive and negative NSCLC, and the potential for targeting ...

Multiple Myeloma Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments

Multiple Myeloma Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments

  • $ 4 995
  • Industry report
  • July 2015
  • by GBI Research

Multiple Myeloma Therapeutics in Major Developed Markets to 2021 - Growth Driven by Rising Prevalence, Continued Success of Revlimid and Emerging Supplementary Treatments Summary Multiple Myeloma (MM) ...

Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2021 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline

Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2021 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline

  • $ 4 995
  • Industry report
  • July 2015
  • by GBI Research

Anti-hypertensive Therapeutics in Asia-Pacific Markets to 2021 - Increasing Prevalence of Hypertension Drives Market Growth despite Weak Pipeline Summary Hypertension is a chronic medical condition characterized ...

Therapy Markets In China

July 2015 $ 4 000

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.